A Post-Marketing Clinical Pharmakokinetics Study Of Gabapentin In Japanese Epileptic Subjects With Renal Impairment.
Phase of Trial: Phase IV
Latest Information Update: 23 Mar 2017
At a glance
- Drugs Gabapentin (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors Pfizer
- 06 Jan 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 25 Jun 2010 Planned end date changed from 1 Feb 2011 to 1 Mar 2011 as reported by ClinicalTrials.gov.
- 25 Jun 2010 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.